{
    "clinical_study": {
        "@rank": "121164", 
        "arm_group": [
            {
                "arm_group_label": "LC28-0126 Dose A", 
                "arm_group_type": "Experimental", 
                "description": "LC28-0126 Dose A"
            }, 
            {
                "arm_group_label": "LC28-0126 Dose B", 
                "arm_group_type": "Experimental", 
                "description": "LC28-0126 Dose B"
            }, 
            {
                "arm_group_label": "LC28-0126 Dose C", 
                "arm_group_type": "Experimental", 
                "description": "LC28-0126 Dose C"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo"
            }
        ], 
        "brief_summary": {
            "textblock": "Evaluate the efficacy, Safety and Pharmacokinetics of Intravenous single injection LC28-0126\n      immediately before PCI (Percutaneous Coronary Intervention) in Patients with STEMI\n      (ST-segment Elevation Myocardial Infarction)"
        }, 
        "brief_title": "Phase 2 Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients", 
        "condition": "ST-segment Elevation Myocardial Infarction", 
        "condition_browse": {
            "mesh_term": [
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age between 20 and  75\n\n          -  Within 12 hours after the onset of chest pain\n\n          -  ST-segment elevation of more than 0.1 mV in two contiguous leads or new LBBB(left\n             bundle-branch block) patients\n\n          -  Signed for written informed consent\n\n        Exclusion Criteria:\n\n          -  Left Main disease\n\n          -  Multi-vessel disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070471", 
            "org_study_id": "LG-CYCL002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Placebo", 
                "description": "Placebo", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "LC28-0126 Dose A", 
                "description": "LC28-0126 Dose A", 
                "intervention_name": "LC28-0126 Dose A", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "LC28-0126 Dose B", 
                "description": "LC28-0126 Dose B", 
                "intervention_name": "LC28-0126 Dose B", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "LC28-0126 Dose C", 
                "description": "LC28-0126 Dose C", 
                "intervention_name": "LC28-0126 Dose C", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 13, 2014", 
        "location": {
            "contact": {
                "last_name": "Hyo-Soo Kim, M.D., Ph.D.", 
                "phone": "82-2-2072-2226"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }, 
                "name": "Seoul National University Hospital"
            }, 
            "investigator": {
                "last_name": "Hyo-Soo Kim, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "4", 
        "official_title": "A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Intravenous Single Injection LC28-0126 Immediately Before PCI (Percutaneous Coronary Intervention) in Patients With STEMI(ST-segment Elevation Myocardial Infarction)", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Ministry of Food and Drug Safety"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "AUC of CK-MB for 72 hours post PCI", 
            "safety_issue": "No", 
            "time_frame": "pre PCI, PCI 0h, 6h, 12h, 18h, 24h, 48h, 72h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070471"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "AUC of Troponin I and CK for 72h post PCI", 
                "safety_issue": "No", 
                "time_frame": "pre PCI, PCI 0h, 6h, 12h, 18h, 24h, 48h, 72h"
            }, 
            {
                "measure": "Infarct size and myocardial function assessed by CMR and Echocardiogram", 
                "safety_issue": "No", 
                "time_frame": "Day 4, 30"
            }
        ], 
        "source": "LG Life Sciences", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LG Life Sciences", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}